Schnock, Kumiko O. http://orcid.org/0000-0002-1107-6399
Dykes, Patricia C.
Albert, Jennifer
Ariosto, Deborah
Cameron, Caitlin
Carroll, Diane L.
Donahue, Moreen
Drucker, Adrienne G.
Duncan, Rosemary
Fang, Linda
Husch, Marla
McDonald, Nicole
Maddox, Ray R.
McGuire, Julie
Rafie, Sally
Robertson, Emilee
Sawyer, Melinda
Wade, Elizabeth
Yoon, Catherine S.
Lipsitz, Stuart
Bates, David W.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Multi-hospital Before–After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors
https://doi.org/10.1007/s40264-018-0637-3
Funding for this research was provided by:
Carefusion Foundation
Article History
First Online: 6 February 2018
Compliance with Ethical Standards
:
: This study was funded by the AAMI and the CareFusion Foundation (2012–2015).
: This study was approved by all study sites’ institutional review boards. All of the data collected were de-identified in the electronic data collection tool, which did not include any protected health information.
: Kumiko Schnock, Patricia Dykes, Catherine Yoon, Stuart Lipsitz, and David Bates received research grants from the CareFusion Foundation. Jennifer Albert, Caitlin Cameron, Nicole Macdonald, Ray Maddox, Sally Rafie, Emilee Robertson, Melinda Sawyer, and Elizabeth Wade received honoraria from the CareFusion Foundation for their participation. Deborah Ariosto, Diane Carroll, Adrienne Drucker, Rosemary Duncan, Marla Husch, Julie McGuire, Linda Fang, and Moreen Donahue declare that they have no conflict of interest. David Bates is a coinventor on patent no. 6029138 held by Brigham and Women’s Hospital on the use of decision support software for medical management, licensed to the Medicalis Corporation. He holds a minority equity position in the privately held company Medicalis, which develops web-based decision support for radiology test ordering. He serves on the board for SEA Medical Systems, which makes intravenous pump technology. He consults for EarlySense, which makes patient safety monitoring systems. He receives equity and cash compensation from QPID, Inc., a company focused on intelligence systems for electronic health records. He receives cash compensation from CDI (Negev), Ltd, which is a not-for-profit incubator for health IT startups. He receives equity from Enelgy, which makes software to support evidence-based clinical decisions. He receives equity from ValeraHealth, which makes software to help patients with chronic diseases. He receives equity from Intensix, which makes software to support clinical decision-making in intensive care. He receives equity from MDClone, which takes clinical data and produces de-identified versions of it. His financial interests have been reviewed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their institutional policies.